Medical Genetic Center, Guangdong Women and Children Hospital, Guangzhou, People's Republic of China.
Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, People's Republic of China.
Emerg Microbes Infect. 2023 Dec;12(1):e2176009. doi: 10.1080/22221751.2023.2176009.
Persistent high-risk human papillomavirus (HPV) infection is the pivotal cause of cervical carcinogenesis. HPV types distribution varies greatly by region, and its long-term changes of prevalence remain to be fully characterized in China. Here, the largest population of 198,111 consecutive women who underwent routine cervical screening were investigated from 2015 to 2021 in Guangzhou, south China. The results showed that the overall HPV prevalence was 21.66% (42,911/198,111), and the annual prevalence increased significantly from 2015 to 2021 ( < 0.001). HPV52, 16, 58, CP8304, 51, 53, 39, and 68 were the most prevalent HPV types. The relative HPV-positive rate correlated positively with the progression of cervical intraepithelial neoplasia ( < 0.001); HPV16 was the predominant carcinogenic type, followed by HPV52 and HPV18. HPV infections were significantly age-specific, and 26.51% (11,375/42,911) of cases were caused by multiple HPV types. In addition, HPV infections typically cleared over a median time of 16 (interquartile range 9-31) months, and the clearance of HPV16 was significantly faster than that of other types ( < 0.001). These findings may serve as a guide for local governments to evaluate HPV vaccination and cervical cancer prevention strategies in south China.
持续的高危型人乳头瘤病毒(HPV)感染是宫颈癌发生的关键原因。HPV 型别分布因地区而异,其流行率的长期变化仍需充分描述。本研究调查了 2015 年至 2021 年期间在中国广州进行常规宫颈筛查的 198111 例连续女性人群,结果显示 HPV 总流行率为 21.66%(42911/198111),且呈逐年显著上升趋势( < 0.001)。HPV52、16、58、CP8304、51、53、39 和 68 是最常见的 HPV 型别。HPV 阳性率与宫颈上皮内瘤变(CIN)的进展呈正相关( < 0.001);HPV16 是主要的致癌型别,其次是 HPV52 和 HPV18。HPV 感染具有明显的年龄特异性,42911 例 HPV 阳性患者中有 26.51%(11375 例)为多重 HPV 型别感染。此外,HPV 感染通常在 16(9-31)个月的中位数时间内清除,HPV16 的清除速度明显快于其他型别( < 0.001)。这些发现可为当地政府评估 HPV 疫苗接种和宫颈癌预防策略提供依据。